Related Experiment Video
Updated: Jun 4, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Novel insights into the circ_0003489/let-7b-5p/GLUT1 axis and its possible role in multiple myeloma
Xiaoyan Wang1, Qinqin Yang2, Yuedi Wu1
1Department of Pharmacy, Zhongshan Hospital Xiamen University, Xiamen 361004, Fujian, China.
Insights
Circular RNA hsa_circ_0003489 promotes multiple myeloma (MM) progression and bortezomib (BTZ) resistance by regulating the let-7b-5p microRNA and GLUT1 glucose transporter axis. Knockdown of circ_0003489 inhibits MM growth and reverses BTZ resistance.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Circular RNAs (circRNAs) play crucial roles in the pathogenesis of multiple myeloma (MM).
- The specific function of hsa_circ_0003489 (circ_0003489) in MM development and bortezomib (BTZ) resistance remains to be elucidated.
Purpose of the Study:
- To investigate the role of circ_0003489 in multiple myeloma (MM) progression.
- To determine the involvement of circ_0003489 in bortezomib (BTZ) resistance in MM.
- To elucidate the molecular mechanism underlying circ_0003489's function in MM.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting for gene and protein expression analysis.
- Cell proliferation, apoptosis, and glycolysis assays (EdU, CF, CCK-8, ECAR, glucose consumption, lactate production) to assess MM cell behavior.
- Dual-luciferase reporter, RNA pull-down assays, and xenograft models to investigate molecular interactions and in vivo effects.
Main Results:
- Circ_0003489 was significantly upregulated in MM patient samples and MM cell lines.
- Silencing circ_0003489 inhibited MM cell proliferation, glycolysis, and bortezomib (BTZ) resistance, while promoting apoptosis.
- Circ_0003489 acted as a sponge for let-7b-5p microRNA, negatively regulating its expression, and let-7b-5p microRNA targeted GLUT1 glucose transporter.
Conclusions:
- Circ_0003489 promotes MM progression and bortezomib (BTZ) resistance.
- The circ_0003489/let-7b-5p microRNA/GLUT1 axis is a key regulator of MM cell malignant behaviors and drug resistance.
- Targeting circ_0003489 may represent a potential therapeutic strategy for overcoming bortezomib resistance in multiple myeloma.
Background:
Circular RNAs (circRNAs) act as vital players in multiple myeloma (MM). Herein, we focused on the function of hsa_circ_0003489 (circ_0003489) in MM development and bortezomib (BTZ) resistance.
Methods:
Relative RNA levels were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Relative protein levels were evaluated by Western blotting or immunohistochemistry (IHC). The 5'-ethynyl-2'-deoxyuridine (EdU) and cell colony formation (CF) assays were conducted for cell proliferation. Cell counting kit-8 assay was used to evaluate the BTZ resistance. Flow cytometry analysis was performed for cell apoptosis analysis. Glycolysis was determined by detecting the levels of ECAR, glucose consumption, and lactate production. Dual-luciferase reporter and RNA pull-down assays were carried out to analyze the relationships of circ_0003489 with let-7b-5p microRNA and glucose transporter 1 (GLUT1) glucose transporter protein. Xenograft models were conducted to assess the function of circ_0003489 in vivo.
Results:
Indeed, as shown by qRT-PCR, bone marrow samples of MM patients showed an upregulation of circ_0003489 RNA in comparison to normal controls (P < 0.0001). In in vitro experiments in MM cells, silencing of circ_0003489 repressed cell proliferation, BTZ resistance, and glycolysis. Furthermore, blocking circ_0003489 facilitated in vitro the apoptosis of MM cells. In vivo experiments showed that silencing circ_0003489 decreased tumor formation. Signaling experiments demonstrated that circ_0003489 sponged let-7b-5p microRNA and negatively regulated let-7b-5p microRNA expression. Loss of let-7b-5p microRNA ameliorated circ_0003489 silencing-mediated effects on MM cell malignant behaviors and BTZ resistance. Moreover, we showed that GLUT1 glucose transporter was targeted by let-7b-5p mircoRNA. GLUT1 enhancement reversed the repressive impacts of let-7b-5p upregulation on MM cell malignant behaviors and BTZ resistance.
Conclusion:
We suggest that circ_0003489 RNA knockdown inhibited MM progression and reversed BTZ-induced resistance of MM growth by let-7b-5p microRNA regulated function of GLUT1 glucose transporter.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018